March 3, 2023
Proposed telehealth prescription rules affect testosterone
Proposed DEA rules would provide safeguards for telemedicine consultations by a medical practitioner who has never conducted an in-person evaluation of a patient that result in the prescribing of a controlled medication for that patient. This would affect prescriptions for compounded testosterone, for instance.
However, the proposed telemedicine rules would allow medical practitioners to prescribe 30-day supplies of both Schedule III-V non-narcotic controlled medications and buprenorphine for the treatment of opioid use disorder.